Show simple item record

dc.contributor.authorVale, CL
dc.contributor.authorBurdett, S
dc.contributor.authorRydzewska, LHM
dc.contributor.authorAlbiges, L
dc.contributor.authorClarke, NW
dc.contributor.authorFisher, D
dc.contributor.authorFizazi, K
dc.contributor.authorGravis, G
dc.contributor.authorJames, ND
dc.contributor.authorMason, MD
dc.contributor.authorParmar, MKB
dc.contributor.authorSweeney, CJ
dc.contributor.authorSydes, MR
dc.contributor.authorTombal, B
dc.contributor.authorTierney, JF
dc.date.accessioned2020-08-24T10:06:55Z
dc.date.issued2016-02
dc.identifier.citationThe Lancet Oncology, 2016, 17 (2), pp. 243 - 256
dc.identifier.issn1470-2045
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3999
dc.identifier.doi10.1016/s1470-2045(15)00489-1
dc.format.extent243 - 256
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAddition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/s1470-2045(15)00489-1
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2016-02
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfThe Lancet Oncology
pubs.issue2
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research
pubs.publication-statusPublished
pubs.volume17
pubs.embargo.termsNot known
icr.researchteamProstate and Bladder Cancer Researchen_US
dc.contributor.icrauthorJames, Nicholasen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0